Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus
Skip Data Menu
|
PlagueDiagnosisClinical diagnosis. Diagnosis of plague is based primarily on clinical suspicion. A patient with a painful bubo accompanied by fever, severe malaise and possible rodent exposure in an endemic area should raise suspicion of bubonic plague. The sudden appearance of large numbers of previously healthy patients with severe, rapidly progressive pneumonia with hemoptysis strongly suggests pneumonic plague as a result of an intentional aerosolization. Laboratory diagnosis. A presumptive diagnosis can be made microscopically by identification of the coccobacillus in Gram (negative), Wright, Giemsa, Wayson's, or more specific immunofluorescent antibody stained smears from lymph node needle aspirate, sputum, blood, or cerebrospinal fluid samples. Bubo aspirates can be obtained by inserting a 20 gauge needle on a 10ml syringe containing 1ml of sterile saline; saline is injected and withdrawn until blood tinged. Definitive diagnosis relies on culturing the organism from clinical specimens. The organism grows slowly at normal incubation temperatures (optimal growth at 25-28 C), and may be misidentified by automated systems (often as Y. pseudotuberculosis) because of delayed biochemical reactions. It may be cultured on blood agar, MacConkey agar, or infusion broth. It will also grow in automated culture systems. Any patient with suspected plague should have blood cultures performed; as bacteremia can be intermittent, multiple cultures should be obtained, preferably prior to receipt of antibiotics (clinical severity permitting). Confirmatory diagnosis via culture commonly takes 48-72 hours (cultures should be held 5-7 days); thus specific antibiotic therapy for plague must not be withheld pending culture results. Confirmative culture-based diagnosis is conducted via specific bacteriophage lysis of the organism, which is available at reference laboratories. Most naturally occurring strains of Y. pestis produce an F1-antigen in vivo, which can be detected in serum samples by specific immunoassay. A single anti-F1 titer of >1:10 by agglutination testing is suggestive of plague, while a single titer of >1:128 in a patient who has not previous been exposed to plague or received a plague vaccine is more specific; a fourfold rise in acute vs. convalescent antibody titers in patient serum is probably the most specific serologic method to confirm diagnosis, but results are available only retrospectively. Most patients will seroconvert to plague within 1-2 weeks of disease onset, but a minority require 3 or more weeks. PCR (using specific primers), is not sufficiently developed yet for routine use but it is a very sensitive and specific technique, currently able to identify as few as 10 organisms per ml. Most clinical assays can be performed in biosafety level 2 (BSL-2) laboratories, whereas procedures producing aerosols or yielding significant quantities of organisms require BSL-3 containment. Differential Diagnosis |